Research Study Findings from University of Utah Health Sciences Center Update Understanding of Blood Proteins (Inherited Disorders of the Fibrinolytic Pathway: Pathogenic Phenotypes and Diagnostic Considerations of Extremely Rare Disorders).

A research study conducted by the University of Utah Health Sciences Center provides new insights into inherited disorders of the fibrinolytic pathway, which are extremely rare. These disorders primarily manifest as hemorrhagic phenotypes and can be challenging to diagnose using conventional coagulation testing. Treatment options for these disorders include pharmacological antifibrinolytics and advances in human plasma-derived plasminogen concentrates. Genetic testing is recommended for patients suspected of having an inherited disorder of the fibrinolytic pathway. For more information, readers can refer to the article "Inherited Disorders of the Fibrinolytic Pathway: Pathogenic Phenotypes and Diagnostic Considerations of Extremely Rare Disorders" published in Seminars in Thrombosis and Hemostasis. [Extracted from the article]